Trials / Completed
CompletedNCT04378660
Artificial Intelligence (AI) Validation Study for Polyp Detection
Artificial Intelligence Validation Trial for Polyp Detection: Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 357 (actual)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
Interventional prospective multicenter study: Polyp detection by an automated endoscopic tool as second observer during routine diagnostic colonoscopy
Detailed description
This is an investigator-initiated multicentre non-randomized prospective interventional trial to validate the performance of a novel state-of-the-art computer-aided diagnostic (CAD) tool in polyp detection implemented as second observer during routine diagnostic colonoscopy and to evaluate its feasibility in daily endoscopy. Patients referred for a screening surveillance or therapeutic colonoscopy will undergo a colonoscopy performed by an endoscopist with moderate to high adenoma detection rate (ADR \> 20% and \< 50%) while a second observer will follow the procedure on a bedside AI-tool to count the number of detections made by the AI system and categorize the results into positive or negative results as follows (1) true positive, (2) false negative, (3) other positive and (4) obvious false positive. When a doubtful detection is made by the AI-system, the second observer will ask to re-evaluate the indicated region. When the detection is clear, the endoscopist and second observer do not communicate. The entire procedure is recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Artificial intelligence for polyp detection | Colonoscopy enriched with artificial intelligence tool developed for polyp detection, implemented as a second observer |
Timeline
- Start date
- 2019-10-30
- Primary completion
- 2020-04-18
- Completion
- 2020-04-18
- First posted
- 2020-05-07
- Last updated
- 2020-05-07
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04378660. Inclusion in this directory is not an endorsement.